Company profile: Accellix
1.1 - Company Overview
Company description
- Provider of a bench-top automated cell phenotyping platform for cell therapy quality control, integrating sample preparation, flow cytometry, and data analysis; pre-configured and custom assay kits for GMP workflows; algorithm-based autoanalysis for real-time cell subset classification; and QC assays to verify instrument performance.
Products and services
- Algorithm-Based Autoanalysis: Automated data analysis software dynamically classifies cell subsets for each run, enabling real-time monitoring and decision-making
- Accellix Automated Cell Phenotyping Platform: A bench-top flow cytometer integrating sample preparation, flow cytometry, and data analysis for cell therapy quality control
- Standard Assay Kits: Pre-configured kits targeting common cell markers to enable rapid deployment in GMP environments with minimal manual handling
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Accellix
Nebion
HQ: Switzerland
Website
- Description: Provider of precise curation and advanced analytics of public and private studies to enable the future of genomic research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nebion company profile →
ProtoKinetix
HQ: United States
Website
- Description: Provider of biotechnology solutions for medical researchers to enhance cell survival and health in vitro and in vivo via AAGP®, a patented anti-aging glycopeptide. Offerings include cell and organ storage, regenerative medicine (e.g., Type 1 diabetes, macular degeneration), transplant support, biomanufacturing support, and clinical research applications in ophthalmology and dermatology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProtoKinetix company profile →
Q Chip
HQ: United Kingdom
Website
- Description: Provider of biopharmaceutical drug delivery, developing a range of sustained-release biogeneric and biotherapies products (Q-Sphera).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Q Chip company profile →
Nektar Therapeutics
HQ: United States
Website
- Description: Provider of therapeutics based on an advanced polymer conjugate chemistry platform, including Rezpegaldesleukin (REZPEG/NKTR-358), a regulatory T cell stimulator targeting the IL-2 receptor complex to address immune imbalances in autoimmune and inflammatory diseases; PEG-CSF Protein to modulate inflammation resolution; and a bivalent TNFR antibody that selectively stimulates TNFR2 to enhance T regulatory cell function.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nektar Therapeutics company profile →
BioLegend
HQ: United States
Website
- Description: Provider of immunological reagents for biomedical research, developing antibodies, recombinant proteins, bioassays, and other research reagents at a state-of-the-art facility in San Diego, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioLegend company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Accellix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Accellix
2.2 - Growth funds investing in similar companies to Accellix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Accellix
4.2 - Public trading comparable groups for Accellix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →